Microplate Dx Limited

medical devices

About

Microplate Dx Limited is a diagnostics company based in Glasgow, Scotland, focused on rapid antibiotic susceptibility testing (AST) to address antimicrobial resistance (AMR). Founded in August 2021, the company specializes in developing innovative solutions for urinary tract infections (UTIs). Their core product, the patented *RapidPlate* technology, delivers results with 96% accuracy in just 30 minutes, enabling healthcare providers to quickly identify the most effective antibiotic treatments. The company combines advanced hardware with sophisticated software algorithms to provide reliable AST results. Microplate Dx aims to improve clinical outcomes by ensuring patients receive the correct antibiotic promptly, thereby supporting antimicrobial stewardship efforts. With a multidisciplinary team and recent funding of £2.5 million, Microplate Dx is committed to advancing its technology and making a significant impact in the field of diagnostics.

Technologies

OutlookAmazon AWSMobile FriendlyVimeoData AnalyticsRemoteAIIoT

Keywords

medical equipment manufacturingrapid antibiotic susceptibility testingbiotechnologybacterial infection testingbiosensor electrodesb2bclinical diagnosticsresearch and development in the physicalengineeringand life scienceshealthcare innovationlife sciencesinfection controlurinary tract infectionsmedical diagnosticshealthcare diagnosticsmedical devicesdata algorithmsinfection diagnosisimpedance-based biosensorsantibiotic susceptibility detectionmicrobial detectiondata processing algorithmshealthcareantimicrobial stewardshipservicesbiosensorsrapidplate technologyhealthtechmicrobial resistance detection

Location

106 Rottenrow, Scotland, United Kingdom, G4 0NW

Related Companies

Companies in the same industry